Skip to main content
. 2024 Sep 20;24:1170. doi: 10.1186/s12885-024-12895-2

Table 2.2.

Subgroup analysis for tumor response in patients with stage IB1-IVB

Stage Parameter N (%)
IB1-IVA Complete Response (CR) 4 (11.1)
Partial Response (PR) 28 (77.8)
Stable Disease (SD) 1 (2.8)
Progressive Disease (PD) 3 (8.3)
ORR (CR + PR), 95%CI 32 (88.9), 73.9–96.9
DCR (CR + PR + SD), 95%CI 33 (91.7), 77.5–98.2
IVB Complete Response (CR) 5 (13.5)
Partial Response (PR) 22 (59.5)
Stable Disease (SD) 6 (16.2)
Progressive Disease (PD) 4 (10.8)
ORR (CR + PR), 95%CI 27 (73.0), 55.9–86.2
DCR (CR + PR + SD), 95%CI 33 (89.2), 74.6–97.0

Data are presented as N (%) unless otherwise specified. Responses were assessed in accordance with RECIST version 1.1. Only confirmed responses were included

ORR, overall response rate; DCR, disease control rate; CI, confidence interval